NYSE · Medical - Devices

ENOV (ENOV) Stock

$29.52 +4.50% NYSE: ENOV Healthcare

Valuation

MetricValue
Price$29.52
Market Cap$1.70B
P/E Ratio5.16
P/B Ratio0.82
P/S Ratio0.53
EPS (TTM)$4.00
52-Week High$36.82
52-Week Low$19.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-55.35%
ROA1.09%
ROCE-1.27%
Gross Margin56.81%
Operating Margin2.70%
Net Margin-49.91%
Debt/Equity0.96
Current Ratio2.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.4B$1.6B$1.7B$2.1B$2.2B
Operating Profit$-63.0M$-71.0M$-66.0M$-776.0M$-19.0M
Net Profit$72.0M$-13.0M$-33.0M$-825.0M$-1.2B
EPS$-2.02$-0.28$-0.61$-14.93$-20.86
Op Margin-4.4%-4.5%-3.9%-36.8%-0.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$8.5B$4.3B$4.5B$4.7B$3.8B
Total Liabilities$3.9B$823.0M$1.1B$2.2B$2.3B
Cash$680.0M$24.0M$36.0M$48.0M$36.0M
Borrowings$2.2B$335.0M$536.0M$1.4B$1.4B

Latest News

ENOV: Lowering target price to $23.00 Argus Research · Jul 15, 2026 Enovis (ENOV) Stock Trades Up, Here Is Why StockStory · Jul 13, 2026 Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care GlobeNewswire · Jul 13, 2026 BMO Capital Initiates Enovis at Outperform With $29 Price Target MT Newswires · Jul 9, 2026 Why Enovis (ENOV) Stock Is Trading Up Today StockStory · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$356.0M$-56.0M$135.0M$114.0M$217.0M
Investing Cash Flow$-425.0M$-282.0M$-365.0M$-1.1B$-377.0M
Financing Cash Flow$-10.0M$1.1B$-91.0M$-14.0M$-10.0M
Net Cash Flow$618.0M$-695.0M$21.0M$3.0M$-12.0M
Free Cash Flow$252.0M$-161.0M$13.0M$-67.0M$20.0M

Valuation & Return Ratios

MetricValue
PEG Ratio3.45
EV / EBITDA7.08
FCF Yield2.97%
Quick Ratio1.05
Interest Coverage-0.54
Return 1Y-5.92%
Return 3Y-59.31%
Return 5Y-67.88%

Ownership

Insiders Held1.63%
Institutions Held121.73%
Institutions Float Held123.74%
Institutional HolderSharesReport Date
Blackrock Inc.9,936,4692026-03-31
American Century Companies Inc4,768,9212026-03-31
Vanguard Portfolio Management LLC3,808,6292026-03-31
Vanguard Capital Management LLC2,552,3512026-03-31
Dimensional Fund Advisors LP2,545,9222026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DCI $96.02 +1.89% 27.09 $11.13B 1.43%
EPAC $37.21 +3.07% 19.52 $1.92B 0.12%
FELE $110.05 +0.12% 29.47 $4.87B 1.11%
GHM $91.41 -8.43% 96.04 $1.07B 0.00%
GRC $82.80 +1.98% 35.14 $2.19B 1.07%

About ENOV

ENOV is led by CEO Damien McDonald, employs 7,367 people, headquartered in US, publicly traded since 2008.

ENOV stock trades at $29.52 with a market capitalization of $1.70B. The stock is valued at a price-to-earnings (P/E) ratio of 5.16, price-to-book of 0.82, price-to-sales of 0.53. Over the past 52 weeks the stock has ranged between $19.27 and $36.82, and currently trades 19.8% below its 52-week high.

On profitability, ENOV generates a return on equity (ROE) of -55.35%, return on capital employed of -1.27%, an operating margin of 2.70%, a net profit margin of -49.91%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides